KineMed

About:

KineMed is a biotechnology company that specializes in providing translational and personalized medicine.

Website: http://www.kinemed.com

Twitter/X: KineMedInc

Top Investors: Stanford Financial Group

Description:

KineMed is a biotechnology company that specializes in providing translational and personalized medicine. The company offers unparalleled insight into the complex biological processes underlying the root causes of disease. It uses the administration of stable (non-radioactive) isotopes to provide high-definition pharmacological measurements of disease activity and drug effects across a wide range of therapy areas, including diseases of the nervous system, metabolic and cardiovascular diseases, cancer, inflammation, and musculoskeletal diseases. It was founded in 2001 and headquartered in Emeryville, California.

Total Funding Amount:

$37.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Emeryville, California, United States

Founded Date:

2001-01-01

Contact Email:

service(AT)kinemed.com

Founders:

David Fineman

Number of Employees:

11-50

Last Funding Date:

2015-07-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai